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The prevalence and management of central post-stroke 




Central post-stroke pain (CPSP) is a poorly diagnosed chronic pain. It is under-treated and usually mismanaged. 
Objective
To establish the prevalence of  CPSP and its management in stroke clinics at a tertiary hospital.
Methods
This was a cross-sectional design with stroke patients and health professionals from the stroke clinic at the tertiary hospital in Zimbabwe. 
Results
Out of  166 stroke survivors, 8% had CPSP. Younger age (<60 years) was significantly associated with CPSP (P<0.003). Pain 
characteristics of  CPSP were hyperaesthesia (10, 71%), electric shocks (9, 64%), temperature allodynia (9, 64%) and allodynia (12, 
86%). Ten health professionals participated in the study: one (10%) reported using Douleur Neuropathique 4 (to diagnose neuropathic 
pain) and two (20%) reported using sensory tests. Four patients (44%) were on paracetamol (acetaminophen) and on weak opiates 
such as codeine. None of  the patients were on anticonvulsants or antidepressants. Two medical doctors (50%) used weak opiates as 
second-line management. Five patients (36%) reported receiving a combination of  massage, stretching, general exercise and moist heat 
or cryotherapy. 
Conclusion
The prevalence of  CPSP in the study group is within international range. There is a need for appropriate management and use of  tests 
and outcome measures for diagnosis of  CPSP.
Key Words; Central post-stroke pain, chronic pain, Zimbabwe
Introduction
Central post-stroke pain (CPSP) is defined by the 
International Association for the Study of  Pain (IASP) as 
‘pain initiated or caused by a primary lesion or dysfunction 
of  the central nervous system’1 and occurs in the absence 
of  other nociceptive, peripheral and psychogenic pain2. 
Aetiology of  neuropathic pain is lesion in the central (brain 
and spinal cord) or peripheral nervous system1, whereas 
CPSP is only as a result of  brain lesions and occurs in the 
body part that corresponds to the cerebrovascular lesion3. 
Allodynia, somatosensory deficits and dysaesthesia are more 
prominent in CPSP4,5. Klit et al.3 also proposed that the 
supporting criteria for diagnosing CPSP also include pain 
descriptors, presence of  allodynia to touch or temperature, 
especially cold, and the absence of  inflammation, local tissue 
damage or pain due to movement. Essentially a diagnosis of  
CPSP is made by exclusion of  other probable causes and this 
makes it difficult to diagnose.
The prevalence of  CPSP varies between 1% and 12% in 
Europe and America6-8. When the CPSP criteria is used 
as proposed by Klit et alpartly owing to the difficulty in 
distinguishing this syndrome from other pain types that can 
occur after stroke (such as shoulder pain, painful spasticity, 
persistent headache, and other musculoskeletal pain 
conditions.3, prevalence has been found to be approximately 
4–11%. There are several factors associated with CPSP 
including younger age9, diabetes and female sex5. Current 
smoking and previous history of  depression as well as 
the baseline severity of  the stroke are also associated with 
CPSP10. The literature on factors associated with CPSP 
seems to be inconclusive on factors such as age, sex, side 
of  stroke and laterality and thus, after literature critique, 
the authors only focused on factors that were identified in 
studies that focused primarily on CPSP. Central post-stroke 
pain may occur 1–2 months post-stroke11 but has a higher 
incidence in the subacute and chronic stages of  stroke than 
acute stages12. 
Patients describe the pain as burning, freezing, cutting 
or squeezing13. Post-stroke pain leads to inhibition of  
movement, depression and inability to perform activities of  
daily living14. It also affects return to employment as well as 
work performance15. Management of  CPSP is difficult as it 
does not respond well to analgesics and non-pharmacologic 
treatments. However, therapeutic effects are found with 
antidepressants and anti-epileptics such as gabapentin, 
lamotrigine and pregabalin16. 
Positive effects on reducing CPSP have been found with 
antidepressants and anti-epileptics including exercise17,18, 
transcutaneous electrical nerve stimulation19, cognitive 
behavioural therapy (CBT)14,20, therapeutic neuroscience 
education (TNE)21,22 and graded motor imagery23. There is 
poor evidence for the use of  trans-cranial direct stimulation, 
trans-cranial magnetic stimulation and caloric vestibular 
stimulation24-26. There is limited information about CPSP 
and its prevalence, as well as its medical and therapeutic 
management in African populations. A search of  the 
literature yielded one published research in Nigeria on an 
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African population, with a CPSP prevalence of  5%27. Thus 
the aim of  this study is to establish the prevalence of  CPSP 
and its management in stroke clinics at a hospital where one 
of  the researchers (CTM) is based which will add to the 
literature for African populations.
Methods 
This was a quantitative, cross-sectional, descriptive study. 
The study was conducted at an academic hospital in Harare, 
Zimbabwe. The hospital has 1800 beds and is a centre 
for training of  medical professions such as medicine, 
rehabilitation and nursing. There were two physicians in 
charge of  the outpatient medical clinic, and five medical 
officers (junior medical doctors), who rotate to other 
specialties every 4 months. The rehabilitation department 
had four physiotherapists and two occupational therapists. 
The hospital has a specialised stroke unit for the management 
of  in-patients during the acute stroke period. After they 
are discharged from hospital these patients are referred 
for continuation of  care at the medical and rehabilitation 
outpatient stroke clinics at the same hospital. The stroke 
survivors and health professionals were recruited from these 
clinics.
Stroke survivors were included in the study according to 
the following criteria: men and women above the age of  18 
years whose first ever stroke had occurred between 1 month 
and 5 years previously; who attended a stroke clinic at the 
hospital; and had confirmation of  a stroke using MRI and 
CT scan of  clinical diagnosis. The exclusion criteria were as 
follows: previous history of  neuropathy or other chronic 
pain not related to stroke; several strokes previously as per 
medical records or patient’s report (to exclude possible non-
neuropathic causes of  pain from previous stroke related 
impairments); aphasia; or dysarthria. 
The sample size for stroke survivors was determined 
using the following: estimate of  the expected proportion 
(p)=12%6,7; desired level of  absolute precision (d)=0.05; and 
estimated design effect (DEFF)=1 (standing for one cluster 
at the hospital) with a sample formula of  n = 1.962 × p(1 
− p)/0.05² = [1.962 × 0.12(1 − 0.12)]/0.052. Therefore a 
minimum sample size of  163 stroke survivors was needed 
for this study; 166 patients participated. All 13 health 
professionals were invited and 10 participated in the study. 
Instrumentation and outcome measures
The Leeds Assessment of  Neuropathic Symptoms and 
Signs (LANSS) was used to detect presence of  pain and 
to positively identify the neuropathic nature of  the pain in 
participants who complained of  pain post-stroke. A total 
score above 12 shows likeliness of  a neuropathic mechanism 
contributing to the pain28. Diagnosis of  CPSP was through 
the use of  screening questions to exclude those with non-
CPSP type pain (nociceptive, peripheral and psychogenic) 
and to check that the affected body part corresponds to the 
cerebrovascular lesion. 
Patient-related information was captured using a self-
designed questionnaire and patients’ treatment notebooks 
and included the following: demographic information, 
drug and rehabilitation interventions, clinical information, 
comorbidities and pain. The following were captured 
through the health professionals’ questionnaire: demographic 
information; level of  experience; knowledge of  CPSP; 
and treatment strategies used. The questionnaire did not 
require the medical doctors to specify drugs and thus only 
drug categories were captured. The questionnaires were 
developed with the aid of  the literature and experts involved 
in the management of  stroke survivors. The panel of  experts 
included two physiotherapists (one with experience in stroke 
rehabilitation and the other in pain management), one 
occupational therapist with experience in stroke rehabilitation 
and one physician. 
Procedure
The data collection period was from January 2017 to May 
2017. Stroke survivors were approached consecutively in 
the hospital medical and rehabilitation stroke clinics and 
invited to participate in the study. For stroke survivors who 
answered in the affirmative to having pain that started after 
the stroke, a sensory examination was conducted and scored 
according to the LANSS. 
The researcher also tested for soft/deep touch and hot/cold 
sensation. Sensation testing was done on the painful area 
as well as the corresponding opposite limb at the same site 
(used as the control/normal). A cotton swab was used to test 
soft touch and the blunt end of  a pen for deep touch. Hot 
sensation was tested using a test tube with warm water at 36–
40 °C and cold sensation using water at 5–10 °C. The second 
part of  the LANSS was administered on the participants 
who complained of  pain on their hemiplegic side. The 
participants were blindfolded to keep their eyes closed 
during this examination. The researcher noted the presence 
of  allodynia by lightly stroking with the cotton wool over the 
painful and the non-painful areas. The researcher also noted 
any altered pin-prick sensation/dysaesthesia in both painful 
and non-painful areas by pressing gently with a toothpick on 
the skin. 
For the health professionals, questionnaires were hand 
delivered. Confidentiality was ensured by providing self-
sealing opaque envelopes for the completed questionnaires 
and a sealed box at the work station for dropping off  
completed questionnaires. A reminder by short messaging 
system or WhatsApp was sent 2 days after delivery of  the 
questionnaire. The sealed boxes were then collected 7 days 
after delivery of  the questionnaires. Ethical clearance was 
obtained from the Joint Research and Ethics Committee 
(JREC/206/16), the Medical Research Committee 
(MRCZ/B/1122) in Zimbabwe and Human Research 
Ethics Committee of  the University of  the Witwatersrand 
(M160619). 
Data analysis 
Data was captured on an Excel spreadsheet and exported to 
Epi-Info 7 for analysis. Descriptive statistics were presented 
as frequencies and percentages. Odds ratios were used to 
measure association between bio-socio-economic factors 
and CPSP.
Results
The number of  stroke patients in the study was 166 with a 
mean age of  60.9±15.6 years that ranged from 24 to 97 years. 
The social demographics of  the stroke patients are presented 
in Table 1. Over two-thirds of  the participants were women 
(70%) and living on less than $50 (USD) average monthly 
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income (67%). Three-quarters (76%) were unemployed 
and 34% were from rural areas. Eighty-four percent of  the 
study population sustained an ischaemic stroke and the rest 
(16%) had haemorrhagic stroke, and 58% had stroke in the 
left hemisphere. Table 2 shows the results of  the LANSS 
scores for all stroke patients. Fourteen patients (8%) had a 
LANSS score >12 (positive for CPSP). The rest of  the study 
participants had pain but it was not considered CPSP.
Table 1. Social demographics of stroke patients (n=166).
 
Table 2. Leeds Assessment of Neuropathic Symptoms and Signs 
(LANSS) scores for stroke patients (n=166).
Patients with central post-stroke pain
The median age of  patients with CPSP was 58 years. 
Ischaemic stroke accounted for 13 of  14 patients (93%) 
and 71% had left stroke. Table 3 shows the descriptions 
of  pain by the CPSP patients using the LANSS tool. Most 
participants had pain that never stopped (43%), and reported 
pain linked with hyperaesthesia (71%). Allodynia was present 
in nearly all participants (86%). Results of  associations 
between demographic/clinical factors and CPSP are shown 
in Table 4. Those who were below 60 years of  age were five 
times more likely to develop CPSP than those aged above 60 
(P<0.0035). 
Table 3. Pain descriptors of central post-stroke pain (n=14).
Table 4. Demographic and clinical factors associated with central 
post-stroke pain (n=14).
Management of central post-stroke pain by health 
professionals
Ten medical professionals (two occupational therapists, four 
physiotherapists, three medical officers and one physician) 
responded to the questionnaire. Eight of  the health 
professionals were in the 20–30 age group and four had 
less than 1 year of  experience practising their profession, 
with the rest having 1–3 years of  experience (two health 
professionals), 4–5 years (two) or greater than 5 years (two). 
The patient treatment notebooks did not indicate a specific 
diagnosis of  CPSP. 
Characteristic Variable n (%)
Sex Male 50 (30)
Female 116 (70)

























1–3 months 20 (12)
3–6 months 82 (49)
>6 months 64 (39)





Variable Characteristics n (%)
Pain frequency Not often 5 (36)
Often 3 (21)
Never stops 6 (43)
Hyperaesthesia Yes 10 (71)
No 4 (29)







Allodynia Yes 12 (86)
No 2 (14)
Hyperalgesia Yes 11 (79)
No 3 (21)




Age <60 yearsb 3 18 5.47 (1.47–20.42) 0.0035
>60 years 11 134




Ischaemicb 13 127 0.30 (0.05–3.12) 0.2
Haemorrhagic 1 25
Diabetes Yesb 2 16 1.41 (0.29–6.86) 0.33
No 12 135
HIV Yesb 1 22 0.45 (0.06–3.65) 0.25
No 13 130
Alcohol Yesb 2 31 0.65 (0.14–3.06) 0.32
No 12 121
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Table 5. Treatment received by patients with central post-stroke 
pain (n=14).
Table 6. Management of central post-stroke pain by health 
professionals (n=10).
Table 5 shows the medications and therapy used by patients 
with CPSP. Some (36%) of  the CPSP patients were not on 
any medication. Paracetamol (acetaminophen) and weak 
opioids such as codeine accounted for approximately 44% 
of  those receiving medication. The management of  CPSP 
as reported by health professionals is presented in Table 6. 
Half  of  the health professionals reported using an inter-
disciplinary approach (referral to other disciplines, active 
engagement and follow up on what they had done) for the 
management of  CPSP. One medical doctor did not know 
what first-line drug management to use for CPSP. Also, 
only one medical doctor referred patients for physiotherapy, 
occupational therapy or psychiatry. Fifty percent of  the 
therapists used heat rub for treatment, whilst 33% used 
moist heat. All the therapists included exercise as part of  
their treatment regimen.
Discussion
Prevalence of central post-stroke pain
Fourteen of  the patients had CPSP and this translated to 8% 
of  this sample. Considering that outpatient stroke burden 
for 2015 at the hospital where this study was conducted 
was 1791 patients, approximately 143 (8%) of  these 
patients would have CPSP. This meant that CPSP was not 
a rare condition. None of  the 14 patients with CPSP had 
a diagnosis of  CPSP prior to this study. This meant that all 
these patients were unlikely to be receiving management in 
line with their condition of  CPSP. It would mean that the 
143 annual CPSP cases at the hospital would also not have 
received management in line with CPSP.  The prevalence rate 
of  8% in this study was within the range of  4–11% as found 
in the literature3,10,29. This prevalence rate was low compared 
with other studies which had follow-up of  patients at pre-
determined intervals9,12. If  follow-up testing sessions had 
been conducted the prevalence may actually have been higher. 
The timing of  recruitment into the study was designed to 
coincide with the prime development of  CPSP12. 
There was a high incidence of  allodynia 12 (86%) in the CPSP 
patients. This is similar to the study by Klit et al.29 who found 
23 of  the patients (66%) had allodynia and dysaesthesia. This 
is also similar to the study by Hansen et al. which found 29 
of  the patients with CPSP (14%) to have provoked allodynia, 
whereas it was spontaneous in 66% of  patients5. Allodynia 
has been found to be a hallmark symptom of  CPSP, and the 
results from this study further confirm this. Temperature-
related pain and electric shocks were reported in 9 of  the 
patients (64%) with CPSP. This was similar to the 62% 
reported by Greenspan et al.30 and the 64% reported by 
Klit et al.29 Allodynia and temperature-related pain/electric 
shocks interfere with activities of  daily living and this may 
lead to patients isolating themselves from physical, social or 
economic activities, and further on may cause disability and 
handicap. Pain frequency was described as ‘never stopping’ 
by six patients with CPSP. This meant their pain would affect 
a substantial part of  their day and possibly inhibit them from 
participating in activities of  daily living and other economic 
activities. 
Bio-socio-economic factors associated with central 
post-stroke pain
Age was the only factor that was found to have an association 
with CPSP in this study. Younger participants (60 years 
and below) were more likely to develop CPSP (P<0.003). 
The ages most affected by CPSP were still economically 
Variable Characteristic n (%)
Drugs Yes 9 (64)
No 5 (36)
Drug type                   NSAIDs 1 (11)
Weak opioids 4 (44)
Paracetamol 4 (44)












Variable Characteristic n (%)
Management 
approacha Multidisciplinary 3 (30)
Interdisciplinary 5 (50)
Monodisciplinary 2 (20)
























Moist heat 2 (33)
Exercise 6 (100)
Heat rub 3 (50)
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productive, meaning that they would lose many work hours 
due to the pain and they would also not fulfil their social 
roles adequately. In a study by Klit et al.29, younger age of  
60 and below was also found to have an association with 
development of  CPSP. Hansen et al.5 also found a significant 
association between age and CPSP, with a mean age of  
60.4±6.2 years. It has not yet been established why younger 
age is associated with CPSP, and it was beyond the scope of  
this study to do so. Further studies into this area are required.
Patients below the age of  65 at government hospitals such as 
the one where this research was conducted are required to pay 
for each service needed. The fees for physician, occupational 
therapy, physiotherapy and drug/medication are all paid 
separately. The patients with CPSP had a median age of  58 
years and were ineligible for free treatment. The majority of  
the patients with CPSP were also living on less than $50 per 
month. This meant that they would not be able to pay for 
the medical services. It is possible that inability to pay would 
seriously compromise their health and quality of  life. All 14 
patients with CPSP were also in the age group of  possible 
economic productivity. Having a debilitating chronic pain 
syndrome such as CPSP would affect their ability to provide 
for themselves and their families financially.
Management of central post-stroke pain by health 
professionals
The scope of  this study was not to measure the knowledge 
of  the medical practitioners of  CPSP; however, the medical 
practitioner participants could identify that CPSP occurred 
after a stroke. Nevertheless, this did not translate to them 
specifically identifying CPSP in the population of  stroke 
patients attending the outpatient clinics. Diagnosis of  
CPSP in this study was done through the use of  screening 
questions to exclude those with non-CPSP type pain and the 
LANSS questionnaire to positively identify the neuropathic 
nature of  the CPSP. The poor identification of  CPSP meant 
that planning for medication availability and rehabilitative 
treatment time would be negatively affected. Patients with 
CPSP would constantly require medications according to the 
evidence-based drug management, and therefore drugs to 
manage the CPSP would have to be stocked in accordance to 
this prevalence. They would also require more rehabilitative 
therapy treatment time, as the pain frequently disrupts 
therapy sessions. 
Evidence-based practice proposes the use of  antidepressants 
and anticonvulsants in the drug management of  CPSP8,26. 
Almost two-thirds of  participants with CPSP (9, 64%) were 
on medication in this study. Paracetamol (44%), weak opiates 
such as codeine (44%) and non-steroidal anti-inflammatory 
drugs (11%) were used. None of  these types of  medication 
used to treat CPSP were of  an evidence-based standard. 
The cost of  antidepressants and anticonvulsants may have 
contributed to the patients not taking any of  these drugs 
as most lived on less than $50 per month and had to pay 
for their medication. Paracetamol was the drug most used. 
It does not need prescription by a medical doctor and is 
affordable, making it easily accessible to most patients. This 
may have accounted for its high usage. The drug treatment 
pattern was similar to that of  Harno et al.9 who also had most 
of  their patients on analgesics such as paracetamol (24, 85%) 
and weak opioids (10, 35%). Within the Essential Drug List 
in Zimbabwe (EDLIZ)31, there is no mention of  treatment 
of  stroke pain and therefore no guidelines as to which drug 
treatment may be useful for stroke pain specifically. However, 
the EDLIZ has guidelines on treatment of  peripheral sensory 
symptoms and recommends the use of  amitriptyline in doses 
from 25 mg to 75 mg once daily, with the lower dose most 
recommended. It further recommends that if  amitriptyline is 
ineffective or causes intolerable adverse effects, then the use 
of  carbamazepine or opiates such as codeine or morphine 
sulfate would be warranted.
Two of  the medical doctors reported they would prescribe 
antidepressants and anticonvulsants. These may not have 
been the doctors who saw the 14 participants with CPSP who 
did not have these medications because the doctors rotate 
regularly from the physician clinics except for the consultant 
physicians themselves. However, the consultant physicians 
only treat patients who are referred by the junior doctors. 
The junior doctors also had limited experience in treating 
stroke patients as most had less than 5 years experience post-
qualification. Thus they would likely know the signs and 
symptoms of  CPSP but would not have had much practical 
experience in treating such a condition and would possibly 
miss a lot of  information. Most of  the health professional 
participants were not using any outcome measures to test for 
CPSP, nor did they use sensation tests or other neurological 
tests. All participants with CPSP were missed on diagnosis 
and this resulted in them being treated in a generic manner 
for chronic pain and not specific to a neuropathic pain such as 
CPSP. Use of  outcome measures and sensation testing could 
be time-consuming and perhaps this accounted for the low 
uptake because the outpatient stroke clinics are usually busy, 
oversubscribed and with a low staff  complement. Having a 
CPSP check-list or an algorithm for use when conducting 
the stroke clinics may assist in picking out patients who have 
CPSP32.
Most participants with CPSP indicated that they received 
one or more therapy type treatments including exercise. 
This study did not investigate in depth the type, frequency 
or grading of  exercise used by patients with CPSP, therefore 
it is not possible to determine whether the exercises used 
were beneficial or detrimental to the CPSP condition. 
Only a third of  therapists used TNE and CBT. The local 
university curriculum may not have included formal teaching 
of  TNE and CBT to both occupational therapists and 
physiotherapists, despite it being commonly used worldwide 
by various medical professionals14,33. A curriculum audit at 
the local university may be required to establish whether the 
CBT and TNE components are taught and the effectiveness 
and applicability of  such training.
Three patients with CPSP (21%) reported being massaged 
for the pain whilst five (35%) received a combination of  
massage, stretch and hot/cold treatments. Although efficacy 
of  treatment was beyond the scope of  this study, these 
treatment modalities may make symptoms such as allodynia 
worse34,35. The efficacy of  these treatments for other CPSP 
symptoms may still require further research in this setting. 
Conclusion
The prevalence of  CPSP is in line with other studies from 
both developed and developing countries. The only bio-
socio-economic factor associated with CPSP in this study is 
younger age. There is need for appropriate management and 
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use of  tests and outcome measures for diagnosis of  CPSP. 
Continued education courses on management of  patients 
with CPSP is required to improve evidence-based practice 
as some of  the service limitations can be attributed to lack 
of  knowledge/experience rather than shortage of  resources.
Limitations
The participants were all from a clinical setting and within 
the sub-acute stage of  stroke (up to 3 months), with very few 
at the chronic stage (>6 months)35. Sampling patients at the 
community level may increase the number of  chronic stage 
participants. The number of  participants with CPSP was 
low compared with those without CPSP and this affected 
the power of  between-group comparisons. Confirmation 
of  CPSP was based on exclusion of  possible nociceptive, 
peripheral and psychogenic causes and on the link between 
area of  pain and cerebrovascular lesion and thus may have 
included patients with complex regional pain syndrome of  
central origin if  patients had trauma that was not reported. 
Given the high female ratio, and the lower social class, these 
results are not generalisable to stroke survivors outside the 
study setting. 
Recommendations
Train health professionals in stroke clinics in CPSP 
assessment and treatment protocols; devise a checklist and 
treatment algorithm for post-stroke pain in general and 
CPSP in particular; raise awareness of  the referral process 
and facilitation of  the CPSP management interdisciplinary 
approach through seminars and team-building exercises; 
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